EUVIMEDEUVIMED entdecken
Crossref

Classification of Brain Tumors by Nanopore Sequencing of Cell-Free DNA from Cerebrospinal Fluid

Ann-Kristin Afflerbach, Christian Rohrandt, Björn Brändl, Marthe Sönksen, Jürgen Hench, Stephan Frank, Daniela Börnigen, Malik Alawi, Martin Mynarek iD, Beate Winkler, Franz Ricklefs iD, Michael Synowitz und 6 weitere

Clinical Chemistry · 04.01.2024 · 70 (1) · 250-260

DOI: 10.1093/clinchem/hvad115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry, online erschienen am 25.08.2023. Verfasst von Ann-Kristin Afflerbach und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, Nanopore Sequencing, Brain Neoplasms. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Molecular brain tumor diagnosis is usually dependent on tissue biopsies or resections. This can pose several risks associated with anesthesia or neurosurgery, especially for lesions in the brain stem or other difficult-to-reach anatomical sites. Apart from initial diagnosis, tumor progression, recurrence, or the acquisition of novel genetic alterations can only be proven by re-biopsies.

Methods

We employed Nanopore sequencing on cell-free DNA (cfDNA) from cerebrospinal fluid (CSF) and analyzed copy number variations (CNV) and global DNA methylation using a random forest classifier. We sequenced 129 samples with sufficient DNA. These samples came from 99 patients and encompassed 22 entities. Results were compared to clinical diagnosis and molecular analysis of tumor tissue, if available.

Results

110/129 samples were technically successful, and 50 of these contained detectable circulating tumor DNA (ctDNA) by CNV or methylation profiling. ctDNA was detected in samples from patients with progressive disease but also from patients without known residual disease. CNV plots showed diagnostic and prognostic alterations, such as C19MC amplifications in embryonal tumors with multilayered rosettes or Chr.1q gains and Chr.6q losses in posterior fossa group A ependymoma, respectively. Most CNV profiles mirrored the profiles of the respective tumor tissue. DNA methylation allowed exact classification of the tumor in 22/110 cases and led to incorrect classification in 2/110 cases. Only 5/50 samples with detected ctDNA contained tumor cells detectable through microscopy.

Conclusions

Our results suggest that Nanopore sequencing data of cfDNA from CSF samples may be a promising approach for initial brain tumor diagnostics and an important tool for disease monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell-Free Nucleic AcidsNanopore SequencingBrain NeoplasmsHumansDNA Copy Number VariationsBiomarkers, TumorMutation

Substanzen

Cell-Free Nucleic AcidsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.
  • Institute for Communications Technologies and Embedded Systems, University of Applied Sciences Kiel, Kiel, Germany.
  • Center for Integrative Psychiatry, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Department of Pathology, University Hospital Basel, Basel, Switzerland.
  • Bioinformatics Core, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

ORCID-Profile: Martin Mynarek, Franz Ricklefs, Annika K Wefers, Melanie Schoof, Ulrich Schüller

Zitieren

APA

Afflerbach, A. K., Rohrandt, C., Brändl, B., Sönksen, M., Hench, J., Frank, S., Börnigen, D., Alawi, M., Mynarek, M., Winkler, B., Ricklefs, F., Synowitz, M., Dührsen, L., Rutkowski, S., Wefers, A. K., Müller, F. J., Schoof, M., & Schüller, U. (2024). Classification of Brain Tumors by Nanopore Sequencing of Cell-Free DNA from Cerebrospinal Fluid. Clinical Chemistry, 70(1), 250-260. https://doi.org/10.1093/clinchem/hvad115

Vancouver

Afflerbach AK, Rohrandt C, Brändl B, Sönksen M, Hench J, Frank S, et al. Classification of Brain Tumors by Nanopore Sequencing of Cell-Free DNA from Cerebrospinal Fluid. Clinical Chemistry. 2024;70(1):250-260. doi:10.1093/clinchem/hvad115

BibTeX
@article{Afflerbach2024,
  author = {Afflerbach, Ann-Kristin and Rohrandt, Christian and Brändl, Björn and Sönksen, Marthe and Hench, Jürgen and Frank, Stephan and Börnigen, Daniela and Alawi, Malik and Mynarek, Martin and Winkler, Beate and Ricklefs, Franz and Synowitz, Michael and Dührsen, Lasse and Rutkowski, Stefan and Wefers, Annika K and Müller, Franz-Josef and Schoof, Melanie and Schüller, Ulrich},
  title = {Classification of Brain Tumors by Nanopore Sequencing of Cell-Free DNA from Cerebrospinal Fluid},
  journal = {Clinical Chemistry},
  year = {2024},
  volume = {70},
  number = {1},
  pages = {250--260},
  doi = {10.1093/clinchem/hvad115}
}
Kostenlos starten →